SCHEMBL2309599

SCHEMBL2309599

O=c1c2cccc(CCO)c2sc2cccc(CCO)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.40
MAPT P10636 4/20 0.36
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 3/20 0.36
POLB P06746 3/20 0.36
CYP2D6 P10635 2/20 0.36
HIF1A Q16665 2/20 0.36
LMNA P02545 2/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 2/20 0.36
ABCB11 O95342 1/20 0.36
TP53 P04637 1/20 0.36
CHRM2 P08172 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
CHRM1 P11229 1/20 0.36
TBXA2R P21731 1/20 0.36
SLC6A2 P23975 1/20 0.36
APEX1 P27695 1/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2312878 0.86 MAOA (0.48) CYP19A1MAPTCYP1A2CYP3A4POLB
SCHEMBL2310829 0.86 CYP19A1 (0.53) CYP19A1MAPTCYP1A2CYP3A4POLB
SCHEMBL2308024 0.84 CYP19A1 (0.40) CYP19A1MAPTCYP3A4POLBLMNA
SCHEMBL2312775 0.84 MAOA (0.33) MAPTCYP1A2CYP3A4POLBRAB9A
SCHEMBL2309510 0.82 MAPT (0.49) CYP19A1MAPTCYP1A2CYP3A4POLB
SCHEMBL2313006 0.77 CYP19A1 (0.40) CYP19A1MAPTPOLBLMNAHTR1A
SCHEMBL2307733 0.77 MAOA (0.40) MAPTCYP1A2CYP3A4POLBRAB9A
SCHEMBL2310251 0.77 MAOA (0.37) MAPTCYP1A2CYP3A4POLBRAB9A
SCHEMBL2307290 0.77 CYP19A1 (0.40) CYP19A1MAPTPOLBLMNARAB9A
SCHEMBL27302486 0.75 MAOA (0.47) CYP19A1MAPTCYP1A2CYP3A4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed